Lew Bender Email

Founder, President & CEO . Intensity Therapeutics

Current Roles

Employees:
13
Revenue:
$2M
About
Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases. Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc.
Intensity Therapeutics Address
1 Enterprise Drive
Westport, CT
United States
Intensity Therapeutics Email
Intensity Therapeutics Phone Numbers
+12032217381

Past Companies

Intensity Therapeutics, Inc.Founder, President & CEO
Interleukin Genetics, Inc.Chief Executive Officer
Emisphere TechnologiesChief Technology Officer

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.